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ARTICLE
Structure-mediated modulation of mRNA
abundance by A-to-I editing
Anneke Brümmer1, Yun Yang1, Tracey W. Chan1 & Xinshu Xiao1
RNA editing introduces single nucleotide changes to RNA, thus potentially diversifying gene
expression. Recent studies have reported significant changes in RNA editing profiles in dis-
ease and development. The functional consequences of these widespread alterations remain
elusive because of the unknown function of most RNA editing sites. Here, we carry out a
comprehensive analysis of A-to-I editomes in human populations. Surprisingly, we observe
highly similar editing profiles across populations despite striking differences in the expression
levels of ADAR genes. Striving to explain this discrepancy, we uncover a functional
mechanism of A-to-I editing in regulating mRNA abundance. We show that A-to-I editing
stabilizes RNA secondary structures and reduces the accessibility of AGO2-miRNA to target
sites in mRNAs. The editing-dependent stabilization of mRNAs in turn alters the observed
editing levels in the stable RNA repertoire. Our study provides valuable insights into the
functional impact of RNA editing in human cells.
DOI: 10.1038/s41467-017-01459-7 OPEN
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RNA editing is a mechanism that alters RNA nucleotides inthe co-transcriptional and post-transcriptional stages ofgene expression1,2. Adenosine-to-inosine (A-to-I) editing is
the most abundant type of RNA editing in mammals, catalyzed by
the protein family called adenosine deaminases acting on RNA
(ADAR). The inosine nucleotide is subsequently recognized as
guanine (G) by the translation machinery. Thus, RNA editing can
induce amino acid changes in coding regions (referred to as
recoding editing sites). A number of such recoding sites have been
shown to be essential to cellular function and development1,3,4.
Although recoding events clearly show the biological sig-
nificance of RNA editing, the majority of RNA editing occurs in
non-coding regions of the mammalian transcriptome with
unknown function5–7. Recent genome-wide studies have identi-
fied significant global alterations of A-to-I editing levels in various
diseases, including cancer, neurological and vascular diseases8–12.
These discoveries call for detailed investigations of the functional
roles of RNA editing, especially those in non-coding regions.
Previous in-depth studies of a small number of editing sites
have identified several functional pathways of RNA editing that
influence different aspects of gene expression, such as
splicing13–15, RNA localization16,17, and RNA stability1,12. In
particular, the impact of RNA editing on RNA stability has been
the focus of a number of studies, given its potentially profound
impact on gene expression. For example, inosine-containing
transcripts are digested by the endonuclease V enzyme, providing
a direct mechanism for the control of RNA stability by A-to-I
editing18. A-to-I editing and ADAR proteins can also indirectly
affect RNA stability by influencing the abundance or sequences of
microRNA (miRNA) molecules, potent regulators of gene
expression1,19–24.
In addition to affecting miRNA sequences or expression, it has
been speculated that A-to-I editing may modify the sequences of
miRNA target sites in the 3′ untranslated regions (UTRs) of
mRNAs. This hypothesis is attractive as it may explain the
functional roles of many editing sites in the non-coding 3′ UTR
regions. In fact, specific examples where A-to-I editing creates or
destroys miRNA target sites have been found25–28. However,
there are seemingly contradictory reports on the predicted pre-
valence of RNA editing sites that alter miRNA target sequences.
Some studies proposed that RNA editing tends to avoid miRNA
target sites29,30, while others suggested that RNA editing is
enriched in miRNA target regions31. Considering these results,
further investigation and rigorous experimental validation are
needed to elucidate the functional roles of non-coding editing
sites in miRNA targeting.
Recent technologies have enabled the production of an extra-
ordinary amount of RNA sequencing (RNA-Seq) data, which has
driven large-scale analyses of RNA editing and its functional
mechanisms. One potentially powerful approach is to analyze the
differences in RNA editomes present in a large number of indi-
viduals. This strategy can uncover the biological, functional or
environmental factors that cause variations in RNA editing. In
this study, we report a comprehensive analysis of RNA editing
across five human populations. Many editing sites are shared
among individuals and have similar editing levels, which are not
fully explained by the expression of ADAR proteins. Through
detailed analyses and corroborating experiments, we characterize
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Fig. 1 Profile of A-to-I editing in human populations. a The total number of RNA-DNA mismatched sites (black bars) identified in RNA-Seq data of each
individual in each population, along with the fraction of A-to-G editing sites among all sites (blue), and the number of uniquely mapped reads per sample
(red). Individuals are grouped by population first and then sorted by the total number of sites. a Prevalence of predicted A-to-I editing sites in each
population. Prevalence of an editing site in a population is defined as % of individuals with the site edited among all individuals with read coverage≥ 10 (i.e.,
testable sites). The total number of unique A-to-I editing sites in each population or in the union of all individuals is included in brackets. c Genomic
distribution of predicted A-to-I editing sites. Intron-close: intronic editing sites within 300 nts from exon-intron boundaries; CDS: coding sequence; UTR:
untranslated region; Intron-deep: intronic editing sites more than 300 nts away from exon-intron boundaries; ncExon: exons in non-coding transcripts.
d Average editing level per population for editing sites in different prevalence groups (number of editing sites in each group is shown in b). Error bars
represent confidence intervals
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a mechanism through which RNA editing in 3′ UTRs affects
miRNA targeting and regulates messenger RNA (mRNA) abun-
dance. Instead of introducing nucleotide changes to miRNA
target sites, we show that RNA editing stabilizes RNA secondary
structures and reduces the accessibility of AGO2-miRNAs to
target sites in mRNA 3′ UTRs. This mechanism may explain the
functional roles of many RNA editing sites located in non-coding
regions. It also highlights the importance of RNA secondary
structure in post-transcriptional gene regulation.
Results
RNA editing sites differ in prevalence within a population. To
obtain a global view of RNA editing in human populations, we
analyzed RNA-Seq data sets of 462 human individuals of the 1000
Genomes project. These subjects represent five populations: Utah
residents with northern and western European ancestries (CEU;
91 individuals), Finnish in Finland (FIN; 95), British in England
and Scotland (GBR; 94), Toscani in Italy (TSI; 93), and Yoruba in
Ibadan, Nigeria (YRI; 87). Lymphoblastoid cell lines were estab-
lished from blood and polyA-selected RNA samples were
sequenced32. RNA-Seq data were analyzed using our previously
developed methods5,33,34 (see Methods).
A total of 28,848 distinct editing sites were identified in the
462 samples. In a single subject, the number of predicted editing
sites ranged from ~ 200 to ~ 3500, which approximately
correlated with RNA-Seq read coverage of the samples (Fig. 1a).
On average, 90% of the editing sites in each individual were of the
A-to-G type, reflecting A-to-I editing (Fig. 1a). This high
percentage suggests a high accuracy of our RNA editing
identification method, as previously shown34. Henceforth, we
will restrict our analyses to A-to-G sites, since non-A-to-G
substitutions constituted a minor fraction and demonstrated little
overlap among individuals in general.
To enable inter-individual comparisons, we further focused on
editing sites that satisfy the following criteria: (1) ≥ 2 reads with
the edited nucleotide and an editing level≥ 0.1 in≥ 3 individuals
of a population; and (2) read coverage≥ 10 in≥ 10% individuals
of a population. These cutoffs were chosen to achieve a trade-off
between the total number of selected sites and the fraction of A-
to-G sites (Supplementary Fig. 1a–c). It should be noted that the
%A-to-G sites among all unique sites in a population was lower
than that among all sites in one individual (Supplementary
Fig. 1b). This is because A-to-G sites, but not non-A-to-G sites,
often occurred in multiple individuals. More than 4300 editing
sites in each population satisfied the above criteria (Fig. 1b). A
total of 8080 editing sites were identified in the union of all
populations, 97% and 61% of which overlapped those in the
RADAR35 and DARNED36 databases, respectively. These 8080
editing sites were located in 909 genes (Supplementary Fig. 1d)
and most often resided in 3′ UTRs (77%), followed by introns
(14%; Fig. 1c). Only a small fraction (1.6%) was found in the
coding regions of mRNAs and in 5′ UTRs (1%). Interestingly,
among genes with the largest number of editing sites, many have
known functions related to immune response with editing sites
exclusively in the 3′ UTRs (Supplementary Fig. 1d). It should be
noted that the above editing sites are a conservative representa-
tion of all editing sites in the populations, due to limited
sequencing depth and possible preclusion of sites in hyper-edited
regions37.
We next analyzed the prevalence of editing sites within each of
the five populations. We defined the prevalence of each editing
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Fig. 2 Comparison of prevalent and rare editing sites. a Sequence preference for positions flanking prevalent and rare A-to-I editing sites, represented using
a two-sample logo program69. A total of 714 prevalent (prevalence> 90%) and 3618 rare (prevalence≤ 10%) editing sites were included, respectively. The
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rare sites (p= 1.4e-9, Fisher’s Exact test). Prevalent and rare editing sites were defined using editing sites of the union of all individuals (same below).
b Average number of paired nucleotides in a sliding window of 9 nucleotides (corresponding to the length of ADAR binding region70) near prevalent (red)
and rare (blue) editing sites, and near random adenosines (gray) located 200–300 nucleotides from editing sites. Shaded areas represent the standard
error of the mean. Horizontal black bar indicates the region where there are significant differences between the numbers of paired nucleotides around
prevalent and rare editing sites (p< 0.01, Wilcoxon Rank-Sum test). c Variance in editing levels across individuals explained by ADAR expression levels
(ADAR1, ADAR2, and ADAR3) in a linear model. Average values of rare (3618 sites), all (8080) and prevalent sites (714) are shown (ordered as the 1st, 2nd,
and 3rd bar in each group, respectively). Error bars represent confidence intervals
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site as the percentage of individuals with the sites edited among
those that were testable for this editing event (i.e., ≥10 read
coverage). The five populations demonstrated similar distribu-
tions of editing site prevalence (Fig. 1b), with the majority of sites
having prevalence <50%. However, a considerable subset of
editing sites (~ 700) in each population had a prevalence of 90%
or higher. In addition, prevalent editing sites showed higher
editing levels than relatively rare sites (Fig. 1d). Note that
detection of low editing levels depends on read coverage, which
may confound the measure of prevalence. As rare sites have
relatively low editing levels, edited reads may not be observed in
all truly edited individuals given limited read coverage. Thus, the
prevalence shown here, especially for rare sites, may be an under-
estimate of the true prevalence, although the majority of rare sites
defined here should have relatively low true prevalence
(Supplementary Fig. 2).
Prevalent editing sites represent strong ADAR substrates. We
next examined the genomic, regulatory and functional features of
rare (≤10% prevalence) and prevalent (>90% prevalence) editing
sites. The regional location within a transcript was highly similar
for the two groups (Supplementary Fig. 3a). In addition, there was
no significant difference in expression levels of genes harboring
these editing sites (Supplementary Fig. 3b). This observation
indicates that the prevalence measure is not confounded by gene
expression level. Indeed, rare editing sites had slightly higher
average read coverage than prevalent sites (Supplementary
Fig. 3c), consistent with our earlier observation that rare editing
sites had relatively low editing levels (Fig. 1d) and thus require
more reads to be detected.
The sequence contexts (±1 nt) of rare and prevalent editing
sites showed a significant difference (Fig. 2a). In particular,
prevalent sites were associated with the typical sequence signature
known for ADAR substrates38,39. The motif UAG was signifi-
cantly more enriched around prevalent sites than rare sites.
Furthermore, compared with rare editing sites, sequences
flanking prevalent sites were in stronger double-stranded
structures (Fig. 2b). Notably, the sequence neighborhood of both
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rare and prevalent editing sites showed a higher propensity for
double-stranded structures than random adenosines located
200–300 nt away from editing sites (Fig. 2b). This observation
indicates that rare editing sites are also ADAR target sites.
Altogether, the above sequence and structural properties suggest
that prevalent editing sites are stronger ADAR substrates
compared to rare sites. It should be noted that the above
sequence and structural differences between rare and prevalent
editing sites may partially reflect the properties of sites with
different editing levels. As prevalent sites have higher editing
levels than rare sites (Fig. 1d), it is expected that they are stronger
ADAR substrates. Consistently, based on linear regression, ADAR
expression levels explained a relatively larger fraction of the
variance in editing levels of prevalent sites than at rare ones
(Fig. 2c). Nevertheless, the stronger correlation between ADAR
expression and editing levels for prevalent sites may have been
partially enabled by the presumably higher accuracy of their
estimated editing levels. Overall, ADAR expression explained a
relatively small fraction of editing variance (on average ~ 11% for
all sites in each population). The same observation holds if ADAR
protein expression levels were used (Supplementary Fig. 4a),
although ADAR mRNA and proteins levels show moderate
correlation (Supplementary Fig. 4b), or if an editing index9 was
used instead of the average editing level (Supplementary Fig. 4c).
In general, this low contribution of ADAR expression to editing
variance could be due to low ADAR expression variability across
individuals or existence of other regulators that mediate editing
variation.
Compared to those with rare editing sites, genes harboring
prevalent editing sites were enriched in functional categories
related to cell-cycle regulation and cell proliferation. Intriguingly,
the most significantly enriched categories were sexual reproduc-
tion and negative regulation of viral genome replication
(Supplementary Fig. 5). No enriched categories were found
among genes with rare editing sites. Our findings are in line with
recent studies that reported the involvement of ADAR1 in innate
immunity40–42 and that A-to-I editing occurs specifically during
sexual reproduction in the wheat scab fungus Fusarium
graminearum43.
Populations share editing sites with low-level differences. With
the above analyses focused on within-population comparisons, we
next examined the differences and similarities of RNA editomes
between populations. Among all editing sites included in Fig. 1b,
the majority was edited in at least 2 populations, with nearly
3000 sites shared by all five populations (Fig. 3a). Only about
100–300 sites were specific to any one of the five populations.
These observed population-specific editing sites were unlikely a
consequence of inadequate power for their detection in other
populations (Supplementary Fig. 6). A pairwise comparison of
RNA editing sites revealed significant overlap between all pairs of
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populations (Fig. 3b). The individual-specific mean editing levels
or editing indexes9 were also highly similar across populations
(Fig. 3c and Supplementary Fig. 7). A differential test revealed
that only a small number of editing sites has significantly different
editing levels across populations (Fig. 3d).
Overall, the YRI population showed the highest level of
difference in RNA editing relative to other populations (Fig. 3b,
d). In particular, YRI and GBR populations appeared to be most
different among all pairwise comparisons, with the smallest
overlap in editing sites and the largest number of differentially
edited sites, and the largest difference in average editing levels
(Fig. 3b–d). It should be noted that although the cross-population
difference is small, this level of difference is still larger than that
between individuals within the same population (Fig. 3e).
Population-wide editing similarity is not explained by ADARs.
To understand the population-wise differences in RNA editing,
we next examined expression levels of the ADAR genes, com-
bining those of ADAR1 isoforms, p110 and p150. Surprisingly, all
three ADARs showed significantly different levels across popu-
lations (Fig. 3f), which is in stark contrast to the relatively similar
average editing levels among the populations (Fig. 3c). Given
these observations, we asked whether other RNA binding proteins
(RBPs) contribute to the observed editing variability. To this end,
we examined expression levels of 507 RBPs using the RNA-Seq
data from this study (requiring average RPKM level> 1). A total
of 13 RBPs were significantly different in ≥4 pairwise compar-
isons between populations (Supplementary Table 1). Among
these proteins, AGO2 was most significant in the CEU vs. YRI
comparison. Notably, between the CEU and YRI populations, we
observed the largest difference in ADAR expression levels, but the
most similar editing levels, compared with other pairs of popu-
lations (Fig. 3c). Interestingly, AGO2 expression was positively
correlated with average editing levels (r= 0.15–0.42, Fig. 4a),
similarly as for ADAR1 (r= 0.18–0.31, Supplementary Fig. 4b).
Correlation between AGO2-miRNA targeting and editing. We
next examined the potential relationship between AGO2 and
RNA editing. As the canonical function of AGO2 is miRNA-
guided transcript destabilization occurring primarily in the
cytoplasm, while editing presumably occurs earlier in the life of
an mRNA, we hypothesized that the apparent correlation
between AGO2 expression and RNA editing levels reflects RNA
editing-dependent AGO2-miRNA targeting, rather than AGO2-
dependent RNA editing.
To test this hypothesis, we obtained a list of predicted miRNA
target sites (combining TargetScan44 and miRCode45 predictions)
in 3′ UTRs that also harbor RNA editing sites. Interestingly, we
observed that editing sites closer to miRNA target sites had higher
editing levels than more distant sites (Fig. 4b). This observation
also holds if only non-Alu editing sites were analyzed
(Supplementary Fig. 8), excluding the possibility that this
tendency may have originated from a difference in mappability
of reads originating from Alu repeats. Similarly, we analyzed
AGO2 knockdown (KD) and control data sets obtained from
K562 cells by the ENCODE project. Consistent with the observed
positive correlation between AGO2 expression and editing levels
in the human populations (Fig. 4a), we detected a global
reduction in editing levels upon AGO2 KD in K562 cells for
editing sites that are within 500 nt from predicted miRNA target
sites (Fig. 4c). This editing difference was not observed at editing
sites in genes without predicted miRNA target sites in their 3′
UTRs (Fig. 4c). These AGO2-related editing changes may be
explained by an editing-dependent AGO2-miRNA targeting.
To provide complementary evidence for the correlation
between editing levels and AGO2-miRNA targeting, we analyzed
ADAR1 KD data obtained from K562 and HepG2 cells by the
ENCODE project. We asked whether miRNA target gene
expression was altered in case of reduced RNA editing. Figure 4d
shows that miRNA target genes that harbor editing sites within
500 nt from miRNA target sites had reduced expression levels
upon ADAR1 KD. As a control, this observation did not hold for
genes without editing sites in their 3′ UTRs. The expressions of
the above edited miRNA target genes demonstrated consistent
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targeting on observed RNA editing levels according to the following model:
AGO2-miRNA preferentially targets unedited version of the transcripts and
has more pronounced impact on sites with low initial editing level (upper)
than those with high initial editing level (lower). Thus, the AGO2-miRNA
targeting buffers the difference in the initial editing levels of the two
categories of editing sites
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directional changes comparing ADAR1 KD data of K562 and
HepG2 cells (Supplementary Fig. 9a).
Altogether, the above data support a model in which AGO2-
miRNA preferentially targets the unedited version of the mRNA.
This model explains the apparent positive correlation of AGO2
expression with RNA editing levels and the observed reduction in
gene expression levels of miRNA target genes upon ADAR1 KD.
AGO2-miRNAs preferentially target unedited mRNA. To fur-
ther support the above model, we carried out a series of analyses
using the population-based RNA-Seq data. All analyses included
genes harboring editing sites in the 3′ UTRs that are within 500 nt
of predicted miRNA target sites. We asked two questions:
(1) among individuals with similar AGO2 and miRNA expression
levels, is there a gene expression difference between those with
high and low ADAR1 expression (Fig. 5a, b)? (2) Among
individuals with similar ADAR1 expression levels, is there a gene
expression difference between those with high vs. low AGO2 and
miRNA expression levels (Fig. 5c, d)?
For the first question, according to the model where AGO2-
miRNAs preferentially target unedited mRNAs, we expect to
observe higher target gene expression levels for individuals with
higher ADAR1 expression. The data are consistent with this
expectation (Fig. 5b). Furthermore, as expected, the target
expression difference was more pronounced in the comparison,
where AGO2 and miRNA levels were high. As a negative control,
no gene expression difference depending on ADAR1 expression
levels was observed for genes with no editing sites close to
miRNA targets (Fig. 5b). For the second question, we observed
significantly lower gene expression levels for individuals with
higher (vs. lower) AGO2 and miRNA levels, as expected for
miRNA target genes (Fig. 5d). Importantly, this difference was
significant only if ADAR1 expression was low, consistent with the
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Fig. 6 Editing-dependent RNA structural changes near AGO2-miRNA target sites. a Profile of relative 7mer accessibility around editing sites located in 3′
UTRs and within 100 nt from predicted miRNA target sites (blue), and around random A positions (red). Y-axis shows log2 fold change in the probability of
accessibility of a 7mer (centered at the position indicated on the x-axis) between structures folded using the edited (G) vs. unedited (A) version of the
sequences calculated using RNAplfold46 (see Methods). Shaded areas represent confidence intervals. Black bar indicates regions with a significant
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d Scheme for the proposed structure-mediated regulation of target mRNA abundance depending on A-to-I editing
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hypothesis that AGO2-miRNA preferentially destabilizes the
unedited version of mRNAs (that are relatively less available for
targeting if ADAR1 is high).
Importantly, data from the population-level analysis (Fig. 5)
and those from protein KD experiments (Fig. 4d) showed
consistent results. We compared genes with lower expression
in individuals with lower (vs. higher) ADAR1 levels to genes
whose expression was reduced upon ADAR1 KD (vs. control)
(Supplementary Fig. 9b, c). The overlap was significantly larger
among genes with 3′ UTR editing sites and miRNA target sites
within 500 nt than among control genes. The same observation
holds for genes with AGO2-dependent expression changes
(Supplementary Fig. 9d).
The above observations provide additional support for our
earlier hypothesis that AGO2-miRNA preferentially destabilizes
unedited mRNAs. Importantly, the impact of this regulation is
most evident if ADAR1 level is low (and, of course, if AGO2-
miRNA levels are high). This editing-dependent modulation of
mRNA abundance in turn induces an apparent increase in
observed editing levels, thereby reducing the observed difference
in editing levels of individuals with high vs. low ADAR1
expression. Figure 5e summarizes the above model and highlights
the apparent increase in editing levels due to AGO2-miRNA-
mediated destabilization of primarily unedited RNA, especially in
the presence of low ADAR1 levels. Importantly, this model is also
consistent with the earlier observation that AGO2 expression
correlates positively with average editing levels (Fig. 4a).
Structure changes due to editing alter AGO2-miRNA targeting.
To understand the underlying mechanism of preferential target-
ing of unedited mRNA by AGO2-miRNA, we first considered the
hypothesis that editing may alter sequences of miRNA target sites
directly. However, we found that the editing sites of interest in
this study rarely (2.2% of all sites) fell into miRNA seed target
regions. Next, we asked whether RNA secondary structures were
different between the edited and unedited sequences. We used
RNAplfold46 to predict the accessibility (i.e., single-strandedness)
of local RNA regions (7 nt windows) in the neighborhood of RNA
editing sites (Methods). As the thermodynamic properties of
inosines are not defined, previous studies have used guanosines,
with closest properties to inosines, to replace inosines in RNA
structure predictions42. Using this approach, we found that
substituting A’s with G’s at the editing sites induced a significant
decrease in accessibility near the edited A (Fig. 6a). This level of
change is significantly larger than that at random A positions
substituted by G’s (Fig. 6a).
On the basis of the RNAfold predictions, about half of the
unedited A’s were opposite to a U nucleotide in the RNA
structure folded using A’s at the editing sites (Fig. 6b). This
opposite nucleotide was often (~ 55%) located within 100 nt from
the editing site (Supplementary Fig. 10). The second most often
observed nucleotide opposite to the unedited A was C (~ 15%),
consistent with previous reports47,48. RNA structures folded using
G’s at the editing sites were also enriched with C’s and U’s at the
opposing positions, thus forming G-C or G-U pairing (together
accounting for >80% of all structures). Thus, the edited
nucleotides more often base-pair than the unedited nucleotides
(80% vs. 52%). These results are consistent with the above
observation of reduced accessibility (i.e., more double-stranded
pairing) in the presence of G’s compared to A’s.
We next asked whether editing-induced structural changes
correlate with altered miRNA target gene expression. We
analyzed the expression difference of miRNA target genes
between individuals with and those without edited sites in these
genes. Interestingly, we observed a significant negative correlation
between the target gene expression difference (expression ratio
calculated as edited/unedited) and the relative accessibility at the
closest miRNA target site (accessibility of G vs. A) (Fig. 6c, see
Supplementary Data 1). It should be noted that the accessibility in
Fig. 6c was calculated at miRNA target sites, most of which (84%)
were located> 10 nt away from the corresponding editing sites.
Thus, the relative accessibility varies in both positive and negative
directions (see Fig. 6a for comparison). To reduce the impact of
possible uncertainties in editing level estimation and secondary
structure prediction, genes with similar distance (differing by≤
10 nt) between editing sites and miRNA target sites were grouped
together and each group’s average values were shown in Fig. 6c.
Altogether, our results suggest that A-to-I editing predominantly
reduces miRNA accessibility (stabilizes the RNA secondary
structure), which prevents AGO2-miRNAs from accessing its
target sites and destabilizing the edited mRNAs (Fig. 6d).
Experimental validation of editing-modulated mRNA abun-
dance. To confirm the above global findings, we experimentally
tested two candidates, the GOLGA3 and GINS1 genes, which both
contain RNA editing sites and miRNA target sites in their 3′
UTRs. These 3′ UTR regions were cloned into the 3′ UTR of a
firefly luciferase minigene (Fig. 7a, Supplementary Table 2,
Methods). The relative locations of RNA editing sites, miRNA
target sites, as well as the predicted RNA secondary structures are
illustrated in Fig. 7b, c. Both genes were confirmed as miRNA
target genes (miR-24 targeting GOLGA3 and miR-26 targeting
GINS1) (Supplementary Fig. 11, Methods). For each minigene, we
first constructed two versions—one harboring an “A” nucleotide
at the RNA editing site and the other, a “G”—representing the
unedited and edited 3′ UTRs, respectively. These constructs were
then transfected into HEK293 cells for analyses.
For both candidates, we observed that the G version of the
minigene had higher expression than the A version in cells that
overexpressed (OE) AGO2, suggesting that the edited transcript
(G version) is less prone to AGO2 regulation (Fig. 7d, e, left
panel, CG/CA comparison; Fig. 7f, left panel, GC/AC compar-
ison). Consistent with this observation, the G version of the
minigene had lower expression than the A version in AGO2
knockdown (KD) cells (Fig. 7d, e, right panel, CG/CA
comparison; Fig. 7f, right panel, GC/AC comparison). The
predicted RNA secondary structures showed that the unedited
transcript had a CA mismatch at the editing site, whereas the
edited version had a CG match (thus more stable) (Fig. 7b, c),
which can explain the above results. Note that the above
quantification was calculated relative to the CA or AC minigenes,
to normalize against possible variability in controls due to
variation in co-transfection efficiency, cellular condition, etc.
The observed differential expression of the A and G-harboring
minigenes may be explained by two possible mechanisms:
alteration of the miRNA binding sequence (beyond the seed
target sequence) or RNA secondary structure, both of which may
change AGO2-miRNA targeting of these genes. To investigate
these possibilities, we constructed mutant versions of the
minigenes with a GG mismatch in the predicted RNA secondary
structure at the RNA editing site (Fig. 7b, c). We observed that
RNA expression level of the GG minigene was similar to that of
the original unedited version of the minigene (Fig. 7e, GG/CA
comparison; Fig. 7f, GG/AC comparison) in both AGO2 OE and
KD cells. This observation suggests that the differential expres-
sion between unedited and pre-edited minigenes is likely due to
changes in the RNA secondary structure, rather than sequence
alterations to the miRNA binding sites. To further confirm this
hypothesis, we created additional mutant minigenes with matches
of identical base-pairing to the original edited minigene versions:
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GC for GOLGA3 and CG for GINS1. Similar to the original edited
minigenes, these mutant minigenes were also less prone to AGO2
regulation than the unedited versions (Fig. 7e, GC/CA compar-
ison; Fig. 7f, CG/AC comparison). Thus, the above results suggest
that the edited version of the transcripts is less responsive to
AGO2 regulation, likely reflecting reduced miRNA accessibility
resulting from stabilized RNA secondary structures. As a negative
control, a similar experiment using a gene without predicted
miRNA target sites in its 3′ UTR did not yield a difference in gene
expression when substituting A with G at the editing site
(Supplementary Fig. 12). These experimental data are consistent
with the global analyses, suggesting that RNA structural changes
due to editing explain the editing-dependent AGO2-miRNA
targeting.
Discussion
In this study, we carried out a global analysis of RNA editomes in
human populations using RNA-Seq data of 462 individuals. The
large amount of data afforded a global view of RNA editing
profiles across human populations. In general, editing sites differ
greatly in their prevalence in a population, ranging from being
very rare to nearly 100% prevalent. Compared to rare sites, pre-
valent editing sites are stronger substrates for ADAR editing and
are associated with higher editing levels. These observations hold
true for all five populations included in this study. Indeed, our
analyses showed that editing profiles of the five populations are
largely similar, with small differences in editing levels of specific
sites. This similarity in editing profiles strikingly contrasted the
significantly different expression levels of the ADAR genes across
populations.
To understand this apparent discrepancy, we conducted a
series of in-depth analyses, supported by experimental valida-
tions, which led to the discovery of a new functional mechanism
by which RNA editing can modulate mRNA abundance. Our
results suggest that the AGO2-miRNA complex preferentially
targets and destabilizes the unedited version of mRNAs that
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harbor editing sites in their 3′ UTRs. Furthermore, this differ-
ential regulation is likely mediated by a difference in RNA sec-
ondary structure caused by RNA editing. In general, the edited
copy of an mRNA has a more stable secondary structure
and renders lower accessibility for miRNA targeting than the
unedited copy.
It has been a challenge in the field to better understand the
functional impact of RNA editing, especially in human cells
where most editing occurs in non-coding regions. Based on
known examples of A-to-I editing sites affecting nuclear retention
of mRNAs16,17 and inosine-specific degradation18, it was specu-
lated that editing generally reduces the expression levels of its
target genes. However, recent large-scale studies in brain revealed
a comprehensive landscape of correlation between mRNA
abundance and RNA editing levels (or ADAR expression levels),
which consists of both positive and negative correlations49,50.
These observations imply that RNA editing may affect mRNA
abundance through a variety of mechanisms, which calls for
systematic analyses to reveal such mechanisms.
Our study revealed one such mechanism where 3′ UTR-
associated A-to-I editing affects mRNA degradation by mod-
ulating RNA secondary structure and accessibility for miRNAs at
their target genes. It should be noted that a general stabilization of
RNA secondary structure by A-to-I editing has been reported
previously47,48. Our data suggested that the unedited versions of
mRNAs are more prone to miRNA targeting, explaining the
existence of positive correlation between mRNA abundance and
RNA editing levels. Previously, ADAR and A-to-I editing were
reported to affect miRNA biogenesis through different mechan-
isms, including editing in primary miRNA transcripts that may
alter mature miRNA sequences, editing-dependent suppression of
miRNA biogenesis steps, or editing-independent regulation due
to interaction/competition between ADAR and miRNA biogen-
esis machineries1,20,51. In addition to affecting miRNA sequences
or abundance, it is conceivable that A-to-I editing may alter the
sequences of mRNA 3′ UTRs targeted by miRNAs. This
hypothesis has been proposed repeatedly26,29,30, given that A-to-I
editing and miRNA target sites both occur frequently in 3′ UTRs.
However, computational analyses showed that RNA editing tends
to avoid miRNA target sites29,30, which argues against this simple
hypothesis. Thus, our results revealed a new mechanism that is
different from previous speculations: miRNA targeting is affected
by RNA structural changes mediated by A-to-I editing rather
than direct alteration of miRNA target site sequences.
It should be noted that the endogenous gene expression
changes caused by RNA editing are generally small in this study,
which is likely due to the relatively low level of RNA editing for
most sites (editing level being 0.1–0.2) and the fact that miRNA
targeting mostly causes small to modest changes in mRNA
expression levels52. Nevertheless, the collective changes exerted
by many RNA editing sites together may be very influential to
cellular function. In addition, such functional impact of RNA
editing may be highly important under certain conditions, such as
environmental stress or diseases, a subject for future
investigations.
Our findings also revealed the complexity in the underlying
mechanisms that account for the observed RNA editing varia-
tions. A conventional view of regulation of RNA editing levels
focuses on direct mechanisms that influence ADAR-mediated
RNA editing. Known mechanisms of such regulation include
contributions by RBPs other than ADARs53,54, or genetic varia-
tions (e.g., single-nucleotide polymorphisms (SNPs)) that may
affect the structural substrates of ADAR editing55,56. In contrast,
our study suggests that the functional consequence of RNA
editing (in affecting mRNA abundance) may in turn alter the
observed editing levels. Editing-dependent changes in AGO2-
miRNA targeting explain, at least partially, the apparent positive
correlation between AGO2 expression and RNA editing levels and
the seemingly conflicting observations of large variations in
ADAR expression and small variations in RNA editing levels
across populations. Nevertheless, our study does not preclude the
existence of additional mechanisms (such as those mediated by
RBPs and SNPs) that may explain population-wide RNA editing
similarity, which should be examined in the future. In addition,
future studies are needed to investigate the underlying mechan-
ism that accounts for the large variations in ADAR expression
across populations.
Recently, an increasing number of studies revealed global or
specific changes in RNA editing profiles in various human dis-
eases or biological processes8–12,49. These studies indicate that
RNA editing may have important functional implications in
biology and disease. However, the functional consequence of the
majority of non-coding editing sites remains elusive. Our study
addresses this pressing question and provides insights into the
functional impact of RNA editing in human cells.
Methods
Identification of RNA editing sites. Raw Fastq files of the Geuvadis RNA-
Sequencing project32 were downloaded from the Geuvadis Data Browser (http://
www.ebi.ac.uk/Tools/geuvadis-das) and mapped to the human genome (hg19) and
Ensembl transcriptome57 using RASER33 with the parameters –m 0.05 –b 0.03.
Potential mismatch positions were identified. A likelihood model was constructed
to identify mismatch sites possibly due to sequencing errors. This model examines
quality scores of the nucleotides, mismatch positions in the read and read coverage
to calculate a log-likelihood ratio (LLR) for each mismatch site. Sites with LLR< 2
were removed as likely sequencing errors5. These mismatch sites were further
filtered to require: (1) read coverage per site≥ 10; (2) number of edited reads ≥ 2;
and (3) editing level (ratio of edited to total reads) ≥ 0.1. Furthermore, mismatch
sites were discarded if they overlapped known SNPs (dbSNP v14158), simple
repeats (downloaded from UCSC table browser, genome.ucsc.edu), homopolymers
of more than 4 nts, or located in introns within 4 nts of a splice junction (using
UCSC and Ensembl gene annotations57)6. At last, we used GIREMI to call the final
editing sites with the aim of distinguishing editing sites from unknown SNPs
without requiring genome sequencing data34.
Genomic context of editing sites. The genomic context of editing sites was
determined using Ensembl gene annotations. If an editing site overlapped multiple
types of genomic regions, its context definition was prioritized as follows: CDS> 3′
UTR > 5′ UTR> non-coding (nc)Exon > Intron-close> Intron-deep > Intergenic.
ncExons refer to exonic regions in non-coding transcripts. Intronic editing sites
were divided into those within 300 nucleotides and those that are further away
from an exon-intron boundary (“Intron-close” and “Intron-deep”, respectively).
The location of editing sites relative to Alu elements was determined using Alu
repeats annotated by RepeatMasker59.
Gene ontology analyses. Enriched gene ontology (GO) terms were obtained for
238 genes with prevalent editing sites compared to 722 genes with rare editing sites
using PANTHER60. Selected GO terms were required to be significantly enriched
(p< 0.05) with≥ 2-fold enrichment among genes harboring prevalent editing sites,
compared to the expected frequency determined using the background gene set
(genes with rare editing sites). In addition, GO categories were discarded if < five
genes were included. A similar analysis was conducted using genes with rare
editing sites as the test set and those with prevalent editing sites as background.
Test for shared and differential editing between populations. The significance
of the number of shared edited sites between two populations was calculated using
a hypergeometric test, with the background set being all 8080 editing sites con-
sidered in this study. Differentially edited sites were identified via a Wilcoxon
Rank-Sum test comparing the editing levels of sites testable in two populations
(p< 0.01). In addition, the absolute difference in average editing levels was required
to be greater than 0.067, which corresponds to a difference of one edited read if the
total read coverage was 15.
Linear regression between editing levels and ADAR levels. Linear regression
was carried out separately for every editing site, taking the editing level as the
dependent variable and all three ADAR expression levels as regressors. Editing sites
were considered if the number of individuals, in which the site was testable
(covered by at least 10 reads), was larger than 10, and there were at least two
different editing levels among these individuals. The least squares solution of the
linear equation was computed using numpy.linalg.lstsq in Python2.7.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01459-7
10 NATURE COMMUNICATIONS |8:  1255 |DOI: 10.1038/s41467-017-01459-7 |www.nature.com/naturecommunications
Differentially expressed RBPs between populations. Differential expression
analysis was performed using DESeq61 on a pair of populations treating individuals
as replicates. Significantly differentially expressed RBPs were identified by an
adjusted p value< 0.01. A list of 584 RBPs was compiled from different sources
(ENCODE RBPs62, splicing factors63–65). Only RBPs with an average RPKM level
> 1 across all individuals were considered.
Predicted miRNA target sites and miRNA expression levels. Genomic coor-
dinates of conserved miRNA target sites predicted by TargetScan5.144 were
downloaded from the UCSC Table Browser (genome.ucsc.edu). In addition,
miRcode45 predicted target sites of conserved miRNAs were also included. For
further analysis, we only included targets sites that were located in 3′ UTRs and
restricted to predicted target genes of the 20 most highly expressed miRNAs in
lymphoblastoid cell lines measured by small RNA-Seq (GEO accession code
GSE41437)66. Normalized miRNA expression levels for 452 individuals were
downloaded from ArrayExpress (http://www.ebi.ac.uk/arrayexpress/files/E-GEUV-
3/GD452.MirnaQuantCount.1.2N.50FN.samplename.resk10.txt).
miRNA targets in groups with different ADAR1 or AGO2 levels. To compare
target gene expression between individuals with high and low ADAR1, but similar
AGO2-miRNA levels (Fig. 5b), we first divided all individuals into three equally
populated groups according to their ADAR1 expression levels, and similarly for
AGO2 and miRNA expression levels, respectively. Subsequently, we compared gene
expression levels between individuals with high and low ADAR1 expression levels,
controlling for AGO2 and miRNA levels. The AGO2 and miRNA expression levels
of the two groups of individuals were required to be insignificantly different (p
value> 0.1, Wilcoxon Rank-Sum test). This comparison was carried out separately
for each miRNA and we required a minimum of 3 individuals in each group. The
comparisons of gene expression levels between individuals with high and low
AGO2-miRNA levels, but similar ADAR1 levels (Fig. 5d), were carried out
similarly.
Analysis of ADAR1 and AGO2 knockdown and control experiments. Duplicated
RNA-Seq data sets of ADAR1 KD and control shRNA transfection in K562 and
HepG2 cells, as well as AGO2 KD and control shRNA transfection in K562 cells
were downloaded from the ENCODE data repository (www.encodeproject.org)
(accession numbers: ENCSR164TLB, ENCSR104OLN, and ENCSR495YSS,
respectively). RNA-Seq reads were mapped using RASER similarly as described
above for the Geuvadis data set. Gene expression levels (RPKM values67) were
calculated using in-house scripts. Expression level of each gene in the two repli-
cated samples of each condition was averaged first, followed by calculation of fold
changes between groups of individuals. Editing sites in AGO2 KD and control cells
were identified as described above.
Secondary structure predictions and related analyses. The RNA secondary
structure was predicted for the region of ±500 nucleotides around an editing site
using RNAfold68. RNAplfold46 was used to calculate the probability for accessi-
bility of a 7mer in the same region using the parameters –u 7 -L 300 –W 400. The
secondary structure and accessibility measure of the edited sequence was calculated
by replacing the “A” with a “G” at the editing site. If multiple editing sites exist in
the same 3′ UTR, each editing site was analyzed separately and included in the final
result.
In Fig. 2b, the number of paired nucleotides in a sliding window of 9
nucleotides (sliding by 1 nucleotide) around editing sites or random A’s was
calculated based on the minimum free energy structure predicted by RNAfold68
using the reference (unedited) sequence. The 9 nt window was centered at the
position given on the x-axis.
The relative accessibility (Fig. 6a, c) was calculated as the log2 difference in
accessibility of a 7mer at each position in the edited and reference structure (see
Supplementary Software 1 and 2). In Fig. 6a, an average for each position was taken
over all editing sites considered. Specifically, a sequence of length 1001 centered at
the editing site was used as input to RNAplfold46. Then, for each position around
the editing site, the probability for accessibility of a 7mer region in the RNA
structure was calculated. This calculation was carried out for both the edited and
unedited version of the 1001 nt sequence. The relative accessibility of a 7mer was
calculated as the log2 difference in accessibilities at each position in the edited and
unedited sequences (with editing site defined as position 0 and the 7mer centered at
a given position). An average for each position was then taken over all editing sites
considered in this analysis. In addition, as a control, the same calculation was done
for random A nucleotides. Control random A’s were chosen to satisfy all of the
following: (1) not editing sites, (2) located in 3′ UTRs, and (3) located 300 to 500 nt
away from editing sites. We replaced such A’s with G’s and calculated the relative
accessibility.
To directly analyze the consequences of editing-dependent structural changes at
predicted miRNA sites (Fig. 6c), we compared the relative 7mer accessibilities at
predicted miRNA target sites to target gene expression differences between
individuals with editing levels ≥ 0.3 and individuals without edited reads, using the
population data. We considered only the closest miRNA target site relative to each
editing site, if multiple existed. In addition we considered only editing sites within
genes of average expression level≥ 0.1 and for which at least three edited and three
non-edited individuals were available. Relative accessibilities and expression ratios
were averaged over miRNA target sites and genes, respectively, with the closest
distance between editing site and miRNA target site falling into the same sliding
window of distances (window size 10 nt, sliding by 1 nt).
The nucleotides opposite to editing sites in the folded RNA structure (Fig. 6b)
were identified in the minimum free energy structures calculated using RNAfold68.
If the editing site was unpaired but one of its immediate neighbors was paired, the
nucleotide next to the opposite nucleotide of the paired neighboring nucleotide was
taken as the opposite nucleotide of the editing site. In all other cases where the
editing site was unpaired, the opposite nucleotide was identified as ‘N’ (see
Supplementary Software).
Plasmid construction. Partial 3′ UTRs of GOLGA3, GINS1, and C1GALT1 were
inserted into the 3′ UTR of the firefly luciferase reporter via Sac I and Xba I cloning
sites (see Supplementary Table 2 for inserted sequences). To make miRNA sponge
vectors, three copies of miR-24 and miR-26 target sequences were inserted into the
3′ UTR of a GFP reporter via EcoRI and BamH I cloning sites (Supplementary
Table 2). AGO2 shRNA was inserted into the pLVX–U6-puro vector via the BamH
I and EcoR I sites. Human AGO2 cDNA with 3 × Flag tags at the N terminal (3 ×
Flag-hAGO2) was cloned into the pLVX-Tight-puro vector via BamH I and Not I
sites.
Lentiviral AGO2 knockdown, overexpression and cell culture. To make lenti-
virus, control or AGO2 shRNA plasmids or 3 × Flag-hAGO2 plasmids were co-
transfected into 293T cells (ATCC, CRL-3216) with pΔ8.9 and pVSV-G in ratio
4:3:2. pTet-on Advanced and pMD2.G vectors were co-transfected into GP2-293
cells (ClonTech, 631458) in ratio 1:1 to produce Tet-on retrovirus. All viruses were
collected at 48 h after transfection. To produce Tet-on HEK293 cells, HEK293 cells
(ATCC, CRL-1573) were infected by the Tet-on retrovirus for 48 h followed by 500
μg per ml G418 selection. Then HEK293 cells were infected by the control or AGO2
shRNA lentivirus, and HEK293-Tet-on cells were infected by the control or 3 ×
Flag-hAGO2 lentivirus for 48 h followed by 2 μg per ml puromycin selection.
HEK293 cells were cultured with DMEM medium containing 10% FBS.
HEK293 cells with AGO2 knockdown were cultured with DMEM medium
containing 10% FBS and 0.5 μg per ml puromycin. HEK293 cells with AGO2
overexpression were cultured with DMEM medium cantaining 10% FBS, 0.5 μg per
ml puromycin and 100 μg per ml G418.
Transfection. A total of 2.5 μg miR-24 or miR-26 sponge vector were transfected
into HEK293 cells. After 24 h of transfection, 2.4 μg sponge, 50 ng reporter and
50 ng reference vector were co-transfected into pre-neutralized HEK293 cells. Cells
were collected at 48 h after transfection. Control, AGO2 knockdown and over-
expression cells were plated into 6-well plates 1 day before the experiment. AGO2
overexpression was induced by 2 μg per ml doxycycline. Then 50 ng reporter and
50 ng reference plasmids (Renilla luciferase) were co-transfected into cells. Cells
were collected 48 h after transfection.
Western blot. AGO2 overexpression was induced by 2 μg per ml doxycycline. Cells
were lysed in RIPA buffer and protease inhibitor (ThermoFisher, 88266) 48 h after
induction, and the total cell lysates were resolved with SDS-PAGE gels. The fol-
lowing antibodies were used: Flag antibody (sc-807, at 1:3000 dilution) and beta-
actin antibody (sc-47778, at 1:3000 dilution) from Santa Cruz, AGO2 antibody
(ab156870, at 1:2000 dilution) from Abcam. The HRP-linked secondary antibodies
from Santa Cruz (goat anti-rabbit IgG-HRP: sc-2004, goat anti-mouse IgG-HRP:
sc-2005, both at 1:2000 dilution) were used and the blots were visualized with the
ECL kit (GE, RPN2232). The uncropped Western blot images for AGO2 OE and
AGO2 KD with controls are shown in Supplementary Fig. 13.
RNA isolation and Real-time qPCR. Total RNA was isolated using TRIZOL
reagent and treated with DNase I (37° C, 1 hr, followed by heat inactivation). A
total of 2 μg total RNA was reverse-transcribed using SuperScript III (Invitrogen).
The qPCR was performed using the PowerUp™ SYBR® Green Master Mix (Thermo
Scientific) and a LightCycler 480 system (Roche) according to manufacturer’s
instructions.
Code availability. Computer scripts used to analyze RNA secondary structures and
accessibility are included as Supplementary Software 1 and 2.
Data availability. All data sets used in this study are publicly available. Raw RNA
sequencing data (paired-end sequencing of polyA-selected RNA) for 462 indivi-
duals of the Geuvadis RNA-Seq project32 were downloaded from http://www.ebi.
ac.uk/ena/data/view/PRJEB3366. RNA-Seq data sets of ADAR1 KD, AGO2 KD and
corresponding control data sets were downloaded from the ENCODE data repo-
sitory (www.encodeproject.org; accession numbers: ENCSR164TLB,
ENCSR104OLN, and ENCSR495YSS). Normalized miRNA expression levels for
452 individuals were downloaded from ArrayExpress (http://www.ebi.ac.uk/
arrayexpress/files/E-GEUV-3/GD452.MirnaQuantCount.1.2N.50FN.samplename.
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resk10.txt). Read counts of miRNAs in lymphoblastoid cell lines measured by small
RNA-Seq were downloaded from GEO (www.ncbi.nlm.nih.gov/geo/; accession
code GSE41437)66.
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